Kids v Cancer

Creating Hope: In Support of the Creating Hope Reauthorization Act, Making the Rare Pediatric Disease Priority Review Voucher Program Permanent

Testimony before the Health Subcommittee of the U.S. House of Representatives Energy and
Commerce Committee, July 29, 2020. Nancy Goodman, Founder of Kids v Cancer more→

The Creating Hope Reauthorization Act Introduced in the Senate!

Today the Creating Hope Reauthorization Act has been introduced in the Senate. The pediatric priority review voucher program encourages the development of new drugs for seriously ill children, including children with cancer. This is a must-pass bill. more→

RACE for Children Act Could Substantially Increase Studies of Pediatric Cancer Drugs (Cancer Therapy Advisor)

The Research to Accelerate Cures and Equity (RACE) for Children Act has the potential to substantially increase the number of required pediatric studies for novel anticancer drugs, according to an analysis of previously approved agents and RACE criteria. more→

FDA Publishes RACE for Children Act Draft Guidance for Industry

Publication of the guidance is the next step in implementation of the RACE for Children Act, which addresses drug development for rare pediatric cancers. It includes lists of molecular targets for which pediatric studies are required or waived. more→

Creating Hope Reauthorization Act of 2019 Introduced in Congress

Introduced in the House of Representatives on 9/20/2019, Creating Hope Reauthorization Act (H. R. 4439) seeks to make the Rare Pediatric Disease Priority Review Voucher program permanent. more→

Another Voucher Sold for $95 Million

Priority review vouchers, created under the Creating Hope Act of 2012 and awarded by FDA since 2014, have brought to market 19 new rare pediatric disease medicines. more→